Callan Family Office’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.26M Buy
5,706
+354
+7% +$160K 0.05% 321
2025
Q4
$2.51M Buy
5,352
+1,671
+45% +$742K 0.05% 310
2025
Q3
$1.82M Buy
3,681
+171
+5% +$96.7K 0.06% 277
2025
Q2
$1.8M Buy
3,510
+1,942
+124% +$905K 0.06% 287
2025
Q1
$672K Sell
1,568
-998
-39% -$485K 0.05% 272
2024
Q4
$1.25M Buy
+2,566
New +$1.34M 0.08% 210

Other funds holding SNPS

Callan Family Office's SNPS Position: Q1 2026 in Review

Callan Family Office increased its Synopsys (SNPS) stake by 6.6% in Q1 2026, buying an estimated $160K and bringing the position to 5,706 shares worth $2.26M. The position accounts for 0.05% of the portfolio, ranked #321.

Callan Family Office first reported a position in SNPS in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.51M in Q4 2025. 1,390 funds tracked by Wall St. Rank hold SNPS as of Q1 2026.

  • Callan Family Office held 5,706 shares of Synopsys worth $2.26M as of Q1 2026.
  • Callan Family Office bought 354 Synopsys shares in Q1 2026, an estimated $160K.
  • Synopsys made up 0.05% of Callan Family Office's portfolio in Q1 2026, its #321 holding.
  • Callan Family Office first reported a position in Synopsys in Q4 2024 and has held it in 6 quarters since.
  • Callan Family Office's Synopsys position peaked at $2.51M in Q4 2025.
  • 1,390 funds tracked by Wall St. Rank held Synopsys as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.